Gilead Sciences Inc. - GILD (NASDAQ-GS)

1.26 (1.97%)
You can buy this stock commission-free or purchase it within a thematic portfolio
Gilead develops and markets products in the HIV/AIDS, liver diseases, respiratory and cardiovascular therapeutic areas

Key Financials

Day Range:64.00 - 65.22
52 Week Range:60.32 - 72.90
Market Cap:82.32B
P/E Ratio:30.60
Div Yield:3.87
Previous close
No Chart Available
Quotes delayed 15 mins.Quotes for securities delayed 15 mins, quotes for crypto are real-time.Quotes for crypto are real-time.Quotes for crypto as of
Quotes for securities delayed 15 mins, quotes for crypto as of Currently November 16, 2019 5:03:41 PM
Purchase GILD in a Thematic Portfolio
A thematic portfolio is an intelligently weighted basket of up to 30 stocks and ETFs. On our platform, you can buy shares of GILD not only as a single stock, but also as part of a thematic portfolio.
Motif Thematic Portfolios with GILD
Cash Flow Kings
Cash Flow Kings 11.9% 1 YR RTN Steady cash flow. Low stock price. What’s not to like? These guys are flying below the radar, and may be worth a look.
Biotech Breakthroughs
Biotech Breakthroughs 14.5% 1 YR RTN Biotech firms are breathing new life into hope for cures for complex diseases like cancer, arthritis and AIDS.
View all motif thematic portfolios with GILD
Community Portfolios with GILD
What Others Think About GILD
Related Companies Within The Biotechnology Sector